James Harraway

James Harraway

Auto-generated profile, based on publicly available information

James Harraway

Department of Cytogenetics, Sullivan Nicolaides Pathology, Brisbane, Qld, Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2023 in Genetics in Medicine
Verified
Journal Article
Closed access
RSRyan J. Schmidt
Ryan J. Schmidt
MSMarcie Steeves
Marcie Steeves
PBPinar Bayrak-Toydemir
Pinar Bayrak-Toydemir
KBKatherine A. Benson
Katherine A. Benson
BCBradley P. Coe
Bradley P. Coe
YFYuxin Fan
Yuxin Fan

1 November 2005 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
JHJames R. Harraway
James R. Harraway
PGPeter M. George
Peter M. George

1 December 2019 in Pathology
Verified
Journal Article
Closed access
AMAdmire Matsika
Admire Matsika
RGRenee Gallagher
Renee Gallagher
MWMark Williams
Mark Williams
CJChristopher Joy
Christopher Joy
ELEmma Lowe
Emma Lowe
JAJane E. Armes
Jane E. Armes

1 December 2021 in Pathology
Verified
Journal Article
Closed access
SMScott Mead
Scott Mead
MLMark Lucas
Mark Lucas
JPJia-Min Pang
Jia-Min Pang
AFAndrew Fellowes
Andrew Fellowes
JHJames Harraway
James Harraway
SFStephen Fox
Stephen Fox

3 April 2025 in Pathology
Verified
Journal Article
Closed access
NBNarelle Barton
Narelle Barton
CJChristopher Joy
Christopher Joy
ACAlison L. Cheah
Alison L. Cheah
FBFiona Bonar
Fiona Bonar
FMFiona Maclean
Fiona Maclean
AVA. Cristina Vargas
A. Cristina Vargas

1 July 2021 in Pathology
Verified
Journal Article
Open access
PDF file
KZK. Ziegenfusz
K. Ziegenfusz
JHJ. Harraway
J. Harraway
ELE. Lee
E. Lee
GTG. Tsikleas
G. Tsikleas
EDE. Duhig
E. Duhig
MWM. Walsh
M. Walsh
Background: ROS1 immunohistochemistry has become routine to triage NSCLC cases lacking EGFR and ALK alterations for subsequent FISH testing to determine patient eligibility for crizotinib therapy. We observed that, in the large majority of cases showing increased ROS1 expression, ROS1 rearrangements were not detected.